Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

被引:0
作者
C R Garrett
H M Hassabo
N A Bhadkamkar
S Wen
V Baladandayuthapani
B K Kee
C Eng
M M Hassan
机构
[1] MD Anderson Cancer Center,Department of Gastrointestinal Medical Oncology
[2] Unit 426,Department of General Oncology
[3] 1515 Holcombe Boulevard,Department of Biostatistics
[4] Houston,undefined
[5] TX,undefined
[6] 77030-4009,undefined
[7] USA,undefined
[8] MD Anderson Cancer Center,undefined
[9] Unit 462,undefined
[10] 1515 Holcombe Boulevard,undefined
[11] Houston,undefined
[12] TX 77030-4009,undefined
[13] USA,undefined
[14] MD Anderson Cancer Center,undefined
来源
British Journal of Cancer | 2012年 / 106卷
关键词
colorectal cancer; metformin; diabetes; overall survival; retrospective review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1374 / 1378
页数:4
相关论文
共 171 条
[1]  
Azoulay L(2011)Metformin and the incidence of prostate cancer in patients with type 2 diabetes Cancer Epidemiol Biomarkers Prev 20 337-344
[2]  
Dell’Aniello S(1996)Metformin N Engl J Med 334 574-579
[3]  
Gagnon B(2011)Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer Cancer 118 1202-1211
[4]  
Pollak M(2011)Use of metformin and the risk of ovarian cancer: a case-control analysis Gynecol Oncol 123 200-204
[5]  
Suissa S(2009)The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 1766-1777
[6]  
Bailey CJ(2010)Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis Cancer Prev Res (Phila) 3 1451-1461
[7]  
Turner RC(2006)Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells Cancer Res 66 10269-10273
[8]  
Bayraktar S(2000)Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I J Biol Chem 275 223-228
[9]  
Hernadez-Aya LF(2010)Chemoprevention meets glucose control Cancer Prev Res (Phila) 3 1049-1052
[10]  
Lei X(2011)Targeting the insulin growth factor pathway in gastrointestinal cancers Oncology (Williston Park) 25 518-526